Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2011; 17(9): 1174-1179
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1174
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1174
Table 2 Present status of surgical treatment
| IFX (-) | IFX (+) | P value | |
| APR | 9/36 | 3/26 | 0.19 |
| Duration from initial surgery to APR, median yr (range) | 2.5 (0-4.3) | 3.9 (1.0-4.1) | 0.79 |
| Hartmann's procedure | 10/36 | 4/26 | 0.25 |
| Duration from initial surgery to Hartmann, median yr (range) | 2.3 (0-7.0) | 0.7 (0-2.9) | 0.22 |
- Citation: Uchino M, Ikeuchi H, Bando T, Matsuoka H, Takesue Y, Takahashi Y, Matsumoto T, Tomita N. Long-term efficacy of infliximab maintenance therapy for perianal Crohn’s disease. World J Gastroenterol 2011; 17(9): 1174-1179
- URL: https://www.wjgnet.com/1007-9327/full/v17/i9/1174.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i9.1174